Better ceftazidime dosing for intensive care infections
Part of Infections clinical trials.
This trial tests whether giving the antibiotic ceftazidime earlier and in a more personalized way helps clear infections faster in ICU patients. It may improve recovery by making sure the right dose reaches your body at the right time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the intensive care unit (ICU) and expected to stay for at least 3 days
- You have an infection that your doctor plans to treat with the antibiotic ceftazidime
- You have an arterial line (a small tube in your artery) for blood tests
- You are not on dialysis and your kidney function is not severely impaired
- You are not pregnant, breastfeeding, or under legal guardianship
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial measures how ceftazidime (an antibiotic) moves through the body and how it works in children with severe infections in the pediatric intensive care unit. It may help doctors choose safer, more effective dosing for kids.
This trial tests a way to give the antibiotic cefepime to ICU patients. It aims to see if the dosing can be adjusted more precisely for each person.
This study looks at how a certain antibiotic (ceftazidime-avibactam) works in people with blood cancers or stem cell transplants, and how the drug levels affect the bacteria. It aims to find the best dosing to fight infections and reduce resistance.
This trial compares two ways of giving a strong antibiotic (meropenem) to ICU patients with pneumonia and sepsis. It aims to see if giving the drug continuously or in shorter intervals works better. This could help clear the infection faster and improve recovery.
This trial checks if giving higher doses of beta-lactam antibiotics (a type of strong antibiotic) right from the start helps people in the ICU with septic shock. It aims to find the best dose to fight the infection quickly.
This study tests whether combining two antibiotics (ceftazidime and fosfomycin) works better than ceftazidime alone for hospitalized adults with serious bacterial infections. If you have a severe infection thought to be caused by Gram-negative bacteria, this trial may offer a new treatment option.
Hear when a new Infection in ICU trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.